AstraZeneca faces potential fines in China
Pharma giant AstraZeneca urged Britain to improve the environment for businesses in order to drive investment, days after it ...
Buying Alexion remains a “fantastic acquisition” for AstraZeneca, the Big Pharma’s CEO has said, even as the company takes a ...
The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.
Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on AstraZeneca (AZN – Research Report), with a ...
A Liberal Democrat peer has accused the government of favouring the south-east of England over Merseyside after AstraZeneca ...
(Reuters) -Strong results from AstraZeneca helped London's blue-chip index notch a record close on Thursday, while a dovish ...
A fresh earnings release was the news development powering AstraZeneca's (NASDAQ: AZN) share price higher on Thursday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback